Eloxx Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ELOX
CUSIP
29014R103
All holders as of
Q4 2022
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 29014R103 since 12/18/2024, largest first.

Filer % of Class Filed
Domicilium Real Estate Fund III LP 13G
18.6% 5/4/2026
Event 4/27/2026
Coastlands Capital LP 13G
10.0% 6/17/2026
Event 6/10/2026
Aberdeen Group plc 13G
9.9% 7/27/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2022 Q4 1 14.6 k $27.0 k
2022 Q3 33 12.7 M $2.14 M
2022 Q2 35 13.0 M $3.51 M
2022 Q1 38 15.0 M $8.42 M
2021 Q4 45 16.6 M $11.7 M
2021 Q3 46 16.1 M $26.0 M
2021 Q2 52 16.7 M $33.2 M
2021 Q1 39 8.64 M $28.7 M
2020 Q4 46 8.73 M $34.6 M
2020 Q3 39 8.63 M $22.7 M
2020 Q2 41 8.70 M $26.4 M
2020 Q1 46 8.70 M $17.1 M
2019 Q4 51 8.98 M $66.7 M
2019 Q3 52 9.40 M $42.5 M
2019 Q2 53 9.87 M $98.9 M
2019 Q1 45 7.56 M $88.3 M
2018 Q4 43 7.72 M $92.7 M
2018 Q3 45 6.96 M $119 M
2018 Q2 44 5.46 M $91.8 M